Sustainability
We invest in innovations that can improve people’s health and work as an active owner for long-term and responsible value creation.
Active ownership for sustainable development
Sustainability is a natural part of KDventures’ operations. Through our investments, we contribute to the development of new pharmaceuticals and medical technology products with the potential to improve people’s health and meet medical needs where today’s treatment options are insufficient.
At the same time, we actively work with environmental, social and governance-related issues – ESG – both in our own operations and through our ownership in the portfolio companies.
Health and innovation at the centre
Our main opportunity to contribute to positive societal development lies in the companies we invest in. We look for innovations that can transform the treatment of serious diseases and create significant value for patients, healthcare and society.
For us, long-term value creation and medical progress go hand in hand. The potential to address a clear medical need is therefore a central part of our investment strategy.
Responsible ownership
As an active owner, we work closely with our portfolio companies and engage in issues that are important for their long-term development. Through board representation and ongoing dialogue, we contribute, among other things, in strategy, corporate governance, financing and organisation.
We work to ensure that the portfolio companies have responsible corporate governance and relevant management of sustainability issues. This includes, among other things, talent supply, gender equality and equal treatment, as well as compliance with applicable rules and requirements.
KDventures’ work is governed by a policy framework that includes, among other things, ethics, environment, gender equality and equal treatment, HR matters, data protection, information security and investments.
Our starting point is that the business should be conducted responsibly, transparently and with respect for people and the environment. The policy framework is reviewed and developed continuously as part of the company’s governance.
KDventures’ own direct environmental impact is limited, but through our investments we have the opportunity to influence much more. We therefore work to ensure that the portfolio companies comply with relevant environmental requirements and limit negative environmental impact from their operations.
At the same time, our greatest contribution to sustainable societal development is clear: helping promising medical innovations develop into treatments and products that can make a difference for patients.
Corporate governance and policy framework
Our formal positions as well as our ways of working regarding corporate governance and the management of sustainability aspects are formalised through our policy framework. The framework consists of external and internal policies as well as internal guidelines and process descriptions for the company’s employees. For more information about policies, you can visit our policy page, or contact us directly for more information.
In KDventures’ corporate governance report, which is published annually in the annual report, it is described in detail how the company is formally governed, who the largest owners are, and what the composition of the Board looks like, including members, committees and members’ independence in relation to owners and management. The corporate governance report also describes the company’s risks and how HR and competence matters are handled.
Our contribution to the global goals.
Good health and well-being
We invest in innovative pharmaceutical projects and medical products that improve people’s health.
Gender equality
We pursue active efforts to increase gender equality both internally and through active ownership in our portfolio companies.
Decent work and economic growth
Through our investments and ownership governance, we promote economic productivity and create increased economic growth.
Sustainable industry, innovation and infrastructure
Our focus on innovative projects and products contributes to increased access to capital for companies and projects in early stages.